Tiantian Yin

Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers.

Qingchang Chen, Jie Liu, Lanmei Chen, 2016, Acta biomaterialia.

PEG modified graphene oxide loaded with EALYLV peptides for inhibiting the aggregation of hIAPP associated with type-2 diabetes.

Qingchang Chen, Yanan Liu, Jie Liu, 2015, Journal of materials chemistry. B.

Effects of Yoga on Blood Glucose and Lipid Profile of Type 2 Diabetes Patients Without Complications: A Systematic Review and Meta-Analysis

Shilin Deng, Shanshan Chen, Tiantian Yin, 2022, Frontiers in Sports and Active Living.

Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease.

Yanan Liu, Guanglong Yuan, Jie Liu, 2019, Journal of colloid and interface science.

Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer's disease treatment.

Yanan Liu, Yanhui Zhou, Jie Liu, 2016, Acta biomaterialia.

Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.

Yanan Liu, Jie Liu, Xianbo Zhou, 2015, Acta biomaterialia.

Enantiomers of cysteine-modified SeNPs (d/lSeNPs) as inhibitors of metal-induced Aβ aggregation in Alzheimer's disease.

Yanan Liu, Jie Liu, Xianbo Zhou, 2015, Journal of materials chemistry. B.

Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.

Jie Liu, Jing Sun, Licong Yang, 2016, ACS applied materials & interfaces.